Position in BMRN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$75,232,112
+$30,481,469 QoQ
Shares Held
1,314,787
+66.0% QoQ
Ownership
0.679%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#24
of 561 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swedbank AB holds $1,373,398,390 across 23 Biotechnology names. BMRN ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
10,726,608 | $601,440,910 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
968,092 | $233,281,129 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
282,444 | $140,298,407 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
189,848 | $118,377,821 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
1,314,787 | $75,232,112 | |
| 6 | EXEL |
Exelixis, Inc.
|
841,778 | $45,801,140 | |
| 7 | INCY |
Incyte Corp
|
371,387 | $42,100,430 | |
| 8 | 775,032 | $24,359,255 |
All Filings in BMRN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $75,232,112 | 1,314,787 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $44,750,643 | 792,187 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $47,350,079 | 796,737 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $25,289,632 | 466,943 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $23,743,906 | 431,943 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $28,403,379 | 432,122 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $27,309,703 | 388,529 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $23,754,592 | 288,529 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $25,863,906 | 296,129 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $44,953,800 | 466,229 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $44,861,925 | 507,029 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $43,949,273 | 507,029 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $49,303,499 | 507,029 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $46,345,823 | 447,829 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $35,682,151 | 420,929 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $43,848,091 | 529,119 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $38,893,711 | 504,458 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $28,357,257 | 320,965 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $25,971,217 | 336,023 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $12,005,263 | 143,879 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $10,864,303 | 143,879 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||